Paradoxical inhibition of cellular protein expression by proteasome inhibitors

Biomolecular Concepts
|December 2, 2014
PubMed

Insights

Proteasome inhibitors, used in cancer therapy, paradoxically downregulate key cancer proteins like FOXM1. This study reveals secondary mechanisms, not just protein stabilization, contribute to their anticancer effects.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Proteasome inhibitors are established anticancer agents.
  • Their precise mechanisms for selective cancer cell targeting remain incompletely understood.
  • While inhibiting proteasome activity stabilizes most proteins, some are paradoxically downregulated.

Purpose of the Study:

  • To investigate the mechanisms behind the paradoxical downregulation of specific proteins by proteasome inhibitors.
  • To identify key cancer-related proteins affected by proteasome inhibitors.
  • To elucidate the role of these downregulation mechanisms in the overall anticancer activity.

Main Methods:

  • Analysis of proteasome inhibitor effects on mRNA and protein expression.
  • Focus on transcription factors and regulators involved in cancer pathways.
  • Postulation of secondary mechanisms overriding direct protein stabilization.

Main Results:

  • Proteasome inhibitors were found to suppress mRNA and protein expression of FOXM1, NPM, and ARF.
  • These proteins are critically involved in cancer development and progression.
  • A hypothesis was proposed: preferential stabilization of negative transcriptional regulators overrides general protein stabilization.

Conclusions:

  • Proteasome inhibitors employ multiple, secondary mechanisms beyond direct protein stabilization.
  • These mechanisms involve regulation of transcription, degradation, or localization of cellular proteins.
  • Further research is needed to identify all suppressed proteins and fully understand their role in proteasome inhibitor anticancer efficacy.

Related Concept Videos

The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
2.0K
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.7K
The Proteasome02:18

The Proteasome

5.2K
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
47
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
82
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
1.6K